# FDA Inspection 1199216 - Oklahoma Blood Institute Northwest - February 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-northwest/63b53f0c-764a-43e5-ae81-4ffe994aa5dd
Source feed: FDA_Inspections

> FDA Inspection 1199216 for Oklahoma Blood Institute Northwest on February 24, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1199216
- Company Name: Oklahoma Blood Institute Northwest
- Inspection Date: 2023-02-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1199216 - 2023-02-24](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-northwest/4754cf99-ca0d-40b9-8204-e0e301b0eda6)
- [FDA Inspection 1068531 - 2018-09-19](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-northwest/85544ecc-f1a7-40a2-8037-f197fbee8247)
- [FDA Inspection 976726 - 2016-05-12](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-northwest/6f9ba269-d576-465d-92c4-214b9ec4c7fd)
- [FDA Inspection 856152 - 2013-11-20](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-northwest/56835ccc-1ed3-43cf-b968-88682adcef36)
- [FDA Inspection 756042 - 2011-12-02](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-northwest/41310be3-2d2e-4fff-b812-1580efadf7c4)

Company: https://www.keypedia.com/companies/oklahoma-blood-institute-northwest/4509c61a-0727-40f3-8d56-1fed2a118e9f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d